ConductScience.org, home

Paper3936738

Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients.

Hosker JP and 4 others. Diabetologia, 1985. Cited by 61 papers, by iCite.

Cite this record

ConductScience Library. Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients. Papers, record 3936738. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3936738

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients.
PubMed
Journal
Diabetologia
PubMed
Year
1985
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
61
iCite
Relative citation ratio, by iCite
2.65
iCite
Revised in PubMed
2019-08-16
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hosker JPJ P
2Burnett MAM A
3Davies EGE G
4Harris EAE A
5Turner RCR C

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes Mellitus, Type 2Major topic
GlucoseMajor topic
Islets of LangerhansMajor topic
Sulfonylurea CompoundsMajor topic
Aged
Blood Glucose
C-Peptide
Chlorpropamide
Glyburide
Humans
Hyperglycemia
Insulin
Insulin Resistance
Middle Aged

Source PubMed

Download CSV of topics

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16121186Relative contributions of insulin deficiency and insulin resistance in maturity-onset diabetes.Lancet1982https://conductscience.org/library/papers/6121186PubMed
2913926Plasma insulin and glucose levels in maturity onset diabetics treated with chlorpropamide.Diabetologia1977https://conductscience.org/library/papers/913926PubMed
314318586FAILURE OF PROLONGED SULFONYLUREA ADMINISTRATION TO ENHANCE INSULOGENIC RESPONSE TO GLYCEMIC STIMULUS.Diabetes1965https://conductscience.org/library/papers/14318586PubMed
47045153Chronic chlorpropamide therapy of noninsulin-dependent diabetes augments basal and stimulated insulin secretion by increasing islet sensitivity to glucose.J Clin Endocrinol Metab1982https://conductscience.org/library/papers/7045153PubMed
5565457Basal normoglycemia attained with chlorpropamide in mild diabetes.Metabolism1978https://conductscience.org/library/papers/565457PubMed
6849812The effect of chronic oral antidiabetic therapy on insulin and glucagon responses to a meal.Diabetes1977https://conductscience.org/library/papers/849812PubMed
77009650Selective potentiation of insulin-mediated glucose disposal in normal dogs by the sulfonylurea glipizide.J Clin Invest1981https://conductscience.org/library/papers/7009650PubMed
8175653Effects of sulfonylurea therapy on insulin binding to mononuclear leukocytes of diabetic patients.Am J Med1976https://conductscience.org/library/papers/175653PubMed
97287908Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus.J Clin Invest1981https://conductscience.org/library/papers/7287908PubMed
10345754Effects of glipizide and food intake on the blood levels of glucose and insulin in diabetic patients.Acta Med Scand1978https://conductscience.org/library/papers/345754PubMed
116759080The long-term effects of chlorpropamide on insulin, C-peptide, and proinsulin secretion.Diabetes Care1982https://conductscience.org/library/papers/6759080PubMed
126337899Potentiation of insulin action by a sulfonylurea in primary cultures of hepatocytes from normal and diabetic rats.Diabetes1983https://conductscience.org/library/papers/6337899PubMed
136028757Effect of chlorpropamide on serum glucose and immunoreactive insulin concentrations in patients with maturity-onset diabetes mellitus.Diabetes1967https://conductscience.org/library/papers/6028757PubMed
14446907Maintenance of basal plasma glucose and insulin concentrations in maturity-onset diabetes.Diabetes1979https://conductscience.org/library/papers/446907PubMed
15631443Kinetics of human C-peptide in man.Diabetes1978https://conductscience.org/library/papers/631443PubMed
16740034Sulphonylureas increase the number of insulin receptors.Nature1978https://conductscience.org/library/papers/740034PubMed
176781962Hormonal and metabolic effects of chlorpropamide, glibenclamide and placebo in a cross-over study in diabetics not controlled by diet alone.Diabetologia1981https://conductscience.org/library/papers/6781962PubMed
185052977Effect of chronic sulfonylurea therapy on plasma insulin and proinsulin levels.J Clin Endocrinol Metab1972https://conductscience.org/library/papers/5052977PubMed
194136696Effect of short and long term chlorpropamide treatment of insulin release and blood-glucose.Lancet1974https://conductscience.org/library/papers/4136696PubMed
201151775Insulin-stimulated entry of glucose into muscle in vivo as a major factor in the regulation of blood glucose.J Physiol1975https://conductscience.org/library/papers/1151775PubMed

See all 30 referencesDownload CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 61 citations.

PMIDTitleJournalYearIn PapersSource
30471094Hypoglycaemic effects of glimepiride in sulfonylurea receptor 1 deficient rat.Br J Pharmacol2019https://conductscience.org/library/papers/30471094PubMed
25810041Within-class differences of the sulfonylureas should be accounted for. Reply to Schrijnders D, Kleefstra N and Landman GWD [letter].Diabetologia2015https://conductscience.org/library/papers/25810041PubMed
25297572The effect of glibenclamide on insulin secretion at normal glucose concentrations.Diabetologia2015https://conductscience.org/library/papers/25297572PubMed
23564921
Expansion of the homeostasis model assessment of β-cell function and insulin resistance to enable clinical trial outcome modeling through the interactive adjustment of physiology and treatment effects: iHOMA2.
Diabetes Care2013https://conductscience.org/library/papers/23564921PubMed
22815837Dietary fibre improves first-phase insulin secretion in overweight individuals.PLoS One2012https://conductscience.org/library/papers/22815837PubMed
10641958The use of sulphonylureas in the elderly.Drugs Aging1999https://conductscience.org/library/papers/10641958PubMed
8521759Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).Drugs1995https://conductscience.org/library/papers/8521759PubMed
8461648Association of low birth weight with beta cell function in the adult first degree relatives of non-insulin dependent diabetic subjects.BMJ1993https://conductscience.org/library/papers/8461648PubMed
7966113Tablet and insulin therapy in type 2 diabetes in the elderly.J R Soc Med1994https://conductscience.org/library/papers/7966113PubMed
7958542Comparative dose-related time-action profiles of glibenclamide and a new non-sulphonylurea drug, AG-EE 623 ZW, during euglycaemic clamp in healthy subjects.Diabetologia1994https://conductscience.org/library/papers/7958542PubMed
7848543Comparative tolerability profiles of oral antidiabetic agents.Drug Saf1994https://conductscience.org/library/papers/7848543PubMed
3538736Insulin secretion and insulin sensitivity defects are a common feature of mild, clinically homogeneous, recently diagnosed type II (non-insulin-dependent) diabetics.Acta Diabetol Lat1986https://conductscience.org/library/papers/3538736PubMed
3301149The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs.Clin Pharmacokinet1987https://conductscience.org/library/papers/3301149PubMed
2656043Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update.Clin Pharmacokinet1989https://conductscience.org/library/papers/2656043PubMed
2528491Long-term gliclazide treatment improves the in vitro glucose-induced insulin release in rats with type 2 (non-insulin-dependent) diabetes induced by neonatal streptozotocin.Diabetologia1989https://conductscience.org/library/papers/2528491PubMed
1907623Chronic exposure to glibenclamide impairs insulin secretion in isolated rat pancreatic islets.J Endocrinol Invest1991https://conductscience.org/library/papers/1907623PubMed
1777653Effect of sulphonylurea on glucose-stimulated insulin secretion in healthy and non-insulin dependent diabetic subjects: a dose-response study.Acta Diabetol1991https://conductscience.org/library/papers/1777653PubMed
1560186Studies on the mechanism of action of sulphonylureas in type II diabetic subjects: gliquidone.J Endocrinol Invest1992https://conductscience.org/library/papers/1560186PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3936738

GET https://conductscience.org/api/papers/v1/3936738/references?page=2